Filing Details

Accession Number:
0000950170-24-086935
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-07-26 16:38:09
Reporting Period:
2024-07-25
Accepted Time:
2024-07-26 16:38:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1658247 Crinetics Pharmaceuticals Inc. CRNX Pharmaceutical Preparations (2834) 263744114
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1886575 F. Stephen Betz C/O Crinetics Pharmaceuticals, Inc.
6055 Lusk Boulevard
San Diego CA 92121
Chief Scientific Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-07-25 3,000 $53.43 75,611 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $53.43 per share. The range of sales prices on the transaction date was $53.41 to $53.45 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.